Share Price and Basic Stock Data
Last Updated: March 6, 2026, 2:14 am
| PEG Ratio | 0.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CP Capital Limited operates within the education sector, focusing on coaching, study materials, and related services. The company’s stock price stood at ₹91.2, with a market capitalization of ₹166 Cr. Over the recent quarters, revenue has demonstrated variability, with a reported revenue of ₹29 Cr in June 2023, followed by a decline to ₹20 Cr in September 2023. However, the revenue rebounded to ₹26 Cr in December 2023, indicating a potential recovery. Annual revenue figures showed a notable increase from ₹54 Cr in March 2022 to ₹85 Cr in March 2023, though it is expected to drop to ₹49 Cr in March 2024. The trailing twelve months (TTM) revenue reported at ₹60 Cr suggests a mixed performance. The company’s revenue from operations per share was ₹31.13 for the year ending in March 2025, reflecting a robust operational capacity. The fluctuation in revenue signals a need for strategic adjustments to stabilize income streams in a competitive educational landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| CP Capital Limited | 167 Cr. | 92.0 | 272/85.3 | 3.97 | 303 | 3.26 % | 9.83 % | 7.30 % | 10.0 |
| Zee Learn Ltd | 182 Cr. | 5.55 | 11.2/4.57 | 9.32 | 5.86 | 0.00 % | 15.4 % | 9.71 % | 1.00 |
| Golden Crest Education & Services Ltd | 129 Cr. | 246 | 674/225 | 920 | 20.8 | 0.00 % | 2.05 % | 1.49 % | 10.0 |
| CL Educate Ltd | 238 Cr. | 44.3 | 121/35.5 | 50.8 | 0.00 % | 2.93 % | 2.41 % | 5.00 | |
| Global Education Ltd | 489 Cr. | 96.1 | 112/41.0 | 22.9 | 22.7 | 1.56 % | 35.9 % | 26.7 % | 2.00 |
| Industry Average | 877.86 Cr | 65.85 | 119.01 | 68.79 | 0.53% | 12.81% | 24.78% | 5.06 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 22 | 25 | 29 | 20 | 26 | 11 | 17 | 15 | 13 | 14 | 15 | 15 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Expenses | 8 | 8 | 48 | 8 | 11 | 6 | 2 | 1 | 3 | 3 | 2 | 4 | 2 |
| Financing Profit | 11 | 14 | -24 | 21 | 9 | 20 | 8 | 15 | 11 | 9 | 11 | 10 | 11 |
| Financing Margin % | 57% | 61% | -95% | 71% | 44% | 76% | 74% | 91% | 73% | 70% | 78% | 68% | 73% |
| Other Income | 1 | 2 | 2 | 2 | 5 | 2 | 7 | 2 | 2 | 1 | 2 | 5 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 11 | 14 | -22 | 21 | 13 | 21 | 14 | 17 | 12 | 10 | 12 | 14 | 13 |
| Tax % | 23% | 24% | -27% | 24% | 13% | 27% | 9% | 27% | 32% | 13% | 31% | 23% | 24% |
| Net Profit | 8 | 11 | -16 | 16 | 12 | 15 | 13 | 12 | 8 | 8 | 9 | 11 | 10 |
| EPS in Rs | 4.43 | 5.93 | -8.99 | 8.93 | 6.33 | 8.27 | 6.88 | 6.81 | 4.63 | 4.59 | 4.73 | 5.92 | 5.58 |
| Gross NPA % | |||||||||||||
| Net NPA % |
Last Updated: February 6, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for CP Capital Limited based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Jun 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Jun 2025) to 13.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Jun 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Jun 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.58. The value appears to be declining and may need further review. It has decreased from 5.92 (Jun 2025) to 5.58, marking a decrease of 0.34.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 23, 2026, 5:16 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 65 | 78 | 76 | 83 | 90 | 101 | 105 | 49 | 54 | 85 | 49 | 57 | 60 |
| Interest | 5 | 5 | 5 | 6 | 7 | 6 | 7 | 5 | 3 | 2 | 3 | 4 | 6 |
| Expenses | 55 | 68 | 55 | 54 | 59 | 64 | 61 | 42 | 24 | 70 | 7 | 8 | 11 |
| Financing Profit | 5 | 5 | 16 | 23 | 24 | 30 | 37 | 2 | 27 | 13 | 39 | 44 | 43 |
| Financing Margin % | 7% | 6% | 21% | 27% | 27% | 29% | 35% | 4% | 49% | 16% | 80% | 78% | 71% |
| Other Income | 13 | 5 | 11 | 12 | 11 | 7 | 5 | 8 | 5 | 6 | 18 | 10 | 14 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Profit before tax | 12 | 4 | 22 | 30 | 30 | 32 | 38 | 6 | 27 | 15 | 54 | 52 | 54 |
| Tax % | 23% | -19% | 34% | 30% | 26% | 24% | 28% | 98% | 17% | 20% | 19% | 26% | |
| Net Profit | 9 | 5 | 14 | 21 | 22 | 24 | 27 | 0 | 23 | 12 | 43 | 38 | 42 |
| EPS in Rs | 5.40 | 3.22 | 7.99 | 11.58 | 12.19 | 13.26 | 14.94 | 0.08 | 12.47 | 6.57 | 23.88 | 20.95 | 23.10 |
| Dividend Payout % | 0% | 31% | 0% | 0% | 0% | 0% | 20% | 1,299% | 8% | 15% | 13% | 14% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -44.44% | 180.00% | 50.00% | 4.76% | 9.09% | 12.50% | -100.00% | -47.83% | 258.33% | -11.63% |
| Change in YoY Net Profit Growth (%) | 0.00% | 224.44% | -130.00% | -45.24% | 4.33% | 3.41% | -112.50% | 52.17% | 306.16% | -269.96% |
CP Capital Limited has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -11% |
| 3 Years: | 3% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 8% |
| 3 Years: | 22% |
| TTM: | -21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 21% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 1:35 am
Balance Sheet
Last Updated: February 1, 2026, 12:30 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 317 | 321 | 335 | 363 | 386 | 410 | 431 | 430 | 453 | 461 | 480 | 527 | 533 |
| Borrowing | 43 | 43 | 47 | 129 | 90 | 75 | 73 | 72 | 26 | 21 | 53 | 42 | 80 |
| Other Liabilities | 19 | 17 | 23 | 25 | 25 | 25 | 21 | 24 | 23 | 61 | 29 | 37 | 16 |
| Total Liabilities | 397 | 399 | 423 | 535 | 519 | 529 | 544 | 543 | 520 | 562 | 581 | 625 | 647 |
| Fixed Assets | 196 | 163 | 163 | 176 | 183 | 189 | 192 | 187 | 204 | 207 | 194 | 190 | 192 |
| CWIP | 34 | 2 | 3 | 8 | 2 | 2 | 3 | 4 | 4 | 0 | 0 | 0 | 0 |
| Investments | 54 | 51 | 47 | 76 | 66 | 39 | 30 | 29 | 4 | 1 | 1 | 1 | 17 |
| Other Assets | 113 | 184 | 210 | 276 | 269 | 298 | 319 | 323 | 307 | 353 | 385 | 433 | 438 |
| Total Assets | 397 | 399 | 423 | 535 | 519 | 529 | 544 | 543 | 520 | 562 | 581 | 625 | 647 |
Below is a detailed analysis of the balance sheet data for CP Capital Limited based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Reserves, as of Sep 2025, the value is 533.00 Cr.. The value appears strong and on an upward trend. It has increased from 527.00 Cr. (Mar 2025) to 533.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 16.00 Cr.. The value appears to be improving (decreasing). It has decreased from 37.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 21.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 647.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 625.00 Cr. (Mar 2025) to 647.00 Cr., marking an increase of 22.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 190.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 16.00 Cr..
- For Other Assets, as of Sep 2025, the value is 438.00 Cr.. The value appears strong and on an upward trend. It has increased from 433.00 Cr. (Mar 2025) to 438.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 647.00 Cr.. The value appears strong and on an upward trend. It has increased from 625.00 Cr. (Mar 2025) to 647.00 Cr., marking an increase of 22.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 12.00 | 25.00 | 8.00 | -75.00 | -31.00 | -11.00 | -12.00 | -30.00 | -2.00 | 49.00 | -46.00 | -34.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 84 | 381 | 391 | 177 | 184 | 186 | 173 | 313 | 154 | 61 | 36 | 0 |
| Inventory Days | 60 | 224 | 166 | 100 | 477 | 182 | ||||||
| Days Payable | 2 | 22 | 26 | 4 | 8 | 2 | ||||||
| Cash Conversion Cycle | 84 | 438 | 391 | 177 | 386 | 327 | 268 | 781 | 334 | 61 | 36 | 0 |
| Working Capital Days | -127 | 270 | 327 | 476 | 415 | 545 | 577 | 1,148 | 842 | 665 | 407 | 570 |
| ROCE % | 3% | 3% | 6% | 8% | 7% | 7% | 8% | 1% | 6% | 3% | 13% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 20.95 | 31.37 | 6.57 | 12.62 | 0.08 |
| Diluted EPS (Rs.) | 20.95 | 31.37 | 6.57 | 12.62 | 0.08 |
| Cash EPS (Rs.) | 22.23 | 33.52 | 8.94 | 14.82 | 2.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 299.94 | 292.36 | 263.92 | 258.82 | 246.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 299.94 | 292.36 | 263.92 | 258.82 | 246.23 |
| Revenue From Operations / Share (Rs.) | 31.13 | 55.84 | 46.92 | 29.81 | 27.04 |
| PBDIT / Share (Rs.) | 32.04 | 43.24 | 11.57 | 19.18 | 8.23 |
| PBIT / Share (Rs.) | 30.49 | 41.07 | 9.28 | 16.91 | 5.91 |
| PBT / Share (Rs.) | 28.18 | 40.17 | 8.28 | 15.13 | 3.17 |
| Net Profit / Share (Rs.) | 20.67 | 31.35 | 6.65 | 12.55 | 0.08 |
| NP After MI And SOA / Share (Rs.) | 20.95 | 31.37 | 6.57 | 12.60 | 0.07 |
| PBDIT Margin (%) | 102.93 | 77.44 | 24.64 | 64.33 | 30.45 |
| PBIT Margin (%) | 97.94 | 73.56 | 19.77 | 56.72 | 21.86 |
| PBT Margin (%) | 90.52 | 71.94 | 17.64 | 50.75 | 11.70 |
| Net Profit Margin (%) | 66.40 | 56.14 | 14.17 | 42.10 | 0.29 |
| NP After MI And SOA Margin (%) | 67.30 | 56.17 | 14.00 | 42.27 | 0.29 |
| Return on Networth / Equity (%) | 6.98 | 10.73 | 2.49 | 4.87 | 0.03 |
| Return on Capital Employeed (%) | 9.99 | 12.66 | 3.15 | 6.20 | 2.23 |
| Return On Assets (%) | 6.10 | 8.92 | 2.12 | 4.41 | 0.02 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
| Total Debt / Equity (X) | 0.07 | 0.06 | 0.04 | 0.05 | 0.14 |
| Asset Turnover Ratio (%) | 0.08 | 0.16 | 0.15 | 0.05 | 0.03 |
| Current Ratio (X) | 2.41 | 3.45 | 7.40 | 7.00 | 4.12 |
| Quick Ratio (X) | 2.10 | 3.43 | 7.31 | 6.93 | 4.06 |
| Inventory Turnover Ratio (X) | 4.95 | 2.23 | 2.10 | 0.39 | 0.41 |
| Dividend Payout Ratio (NP) (%) | 19.09 | 9.56 | 30.43 | 0.00 | 1261.65 |
| Dividend Payout Ratio (CP) (%) | 17.77 | 8.94 | 22.57 | 0.00 | 41.63 |
| Earning Retention Ratio (%) | 80.91 | 90.44 | 69.57 | 0.00 | -1161.65 |
| Cash Earning Retention Ratio (%) | 82.23 | 91.06 | 77.43 | 0.00 | 58.37 |
| Interest Coverage Ratio (X) | 13.87 | 47.93 | 11.58 | 10.78 | 3.00 |
| Interest Coverage Ratio (Post Tax) (X) | 9.95 | 35.74 | 7.66 | 8.06 | 1.03 |
| Enterprise Value (Cr.) | 796.39 | 541.28 | 400.98 | 212.56 | 292.59 |
| EV / Net Operating Revenue (X) | 14.06 | 5.33 | 4.70 | 3.92 | 5.95 |
| EV / EBITDA (X) | 13.66 | 6.88 | 19.06 | 6.09 | 19.53 |
| MarketCap / Net Operating Revenue (X) | 13.40 | 5.05 | 4.57 | 3.71 | 4.85 |
| Retention Ratios (%) | 80.90 | 90.43 | 69.56 | 0.00 | -1161.65 |
| Price / BV (X) | 1.39 | 0.96 | 0.81 | 0.42 | 0.53 |
| Price / Net Operating Revenue (X) | 13.40 | 5.05 | 4.57 | 3.71 | 4.85 |
| EarningsYield | 0.05 | 0.11 | 0.03 | 0.11 | 0.00 |
After reviewing the key financial ratios for CP Capital Limited, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 20.95. This value is within the healthy range. It has decreased from 31.37 (Mar 24) to 20.95, marking a decrease of 10.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 20.95. This value is within the healthy range. It has decreased from 31.37 (Mar 24) to 20.95, marking a decrease of 10.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 22.23. This value is within the healthy range. It has decreased from 33.52 (Mar 24) to 22.23, marking a decrease of 11.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 299.94. It has increased from 292.36 (Mar 24) to 299.94, marking an increase of 7.58.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 299.94. It has increased from 292.36 (Mar 24) to 299.94, marking an increase of 7.58.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 31.13. It has decreased from 55.84 (Mar 24) to 31.13, marking a decrease of 24.71.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.04. This value is within the healthy range. It has decreased from 43.24 (Mar 24) to 32.04, marking a decrease of 11.20.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.49. This value is within the healthy range. It has decreased from 41.07 (Mar 24) to 30.49, marking a decrease of 10.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 40.17 (Mar 24) to 28.18, marking a decrease of 11.99.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.67. This value is within the healthy range. It has decreased from 31.35 (Mar 24) to 20.67, marking a decrease of 10.68.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 20.95. This value is within the healthy range. It has decreased from 31.37 (Mar 24) to 20.95, marking a decrease of 10.42.
- For PBDIT Margin (%), as of Mar 25, the value is 102.93. This value is within the healthy range. It has increased from 77.44 (Mar 24) to 102.93, marking an increase of 25.49.
- For PBIT Margin (%), as of Mar 25, the value is 97.94. This value exceeds the healthy maximum of 20. It has increased from 73.56 (Mar 24) to 97.94, marking an increase of 24.38.
- For PBT Margin (%), as of Mar 25, the value is 90.52. This value is within the healthy range. It has increased from 71.94 (Mar 24) to 90.52, marking an increase of 18.58.
- For Net Profit Margin (%), as of Mar 25, the value is 66.40. This value exceeds the healthy maximum of 10. It has increased from 56.14 (Mar 24) to 66.40, marking an increase of 10.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 67.30. This value exceeds the healthy maximum of 20. It has increased from 56.17 (Mar 24) to 67.30, marking an increase of 11.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.98. This value is below the healthy minimum of 15. It has decreased from 10.73 (Mar 24) to 6.98, marking a decrease of 3.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.99. This value is below the healthy minimum of 10. It has decreased from 12.66 (Mar 24) to 9.99, marking a decrease of 2.67.
- For Return On Assets (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 8.92 (Mar 24) to 6.10, marking a decrease of 2.82.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.08. It has decreased from 0.16 (Mar 24) to 0.08, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.41, marking a decrease of 1.04.
- For Quick Ratio (X), as of Mar 25, the value is 2.10. This value exceeds the healthy maximum of 2. It has decreased from 3.43 (Mar 24) to 2.10, marking a decrease of 1.33.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.95. This value is within the healthy range. It has increased from 2.23 (Mar 24) to 4.95, marking an increase of 2.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.09. This value is below the healthy minimum of 20. It has increased from 9.56 (Mar 24) to 19.09, marking an increase of 9.53.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.77. This value is below the healthy minimum of 20. It has increased from 8.94 (Mar 24) to 17.77, marking an increase of 8.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.91. This value exceeds the healthy maximum of 70. It has decreased from 90.44 (Mar 24) to 80.91, marking a decrease of 9.53.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.23. This value exceeds the healthy maximum of 70. It has decreased from 91.06 (Mar 24) to 82.23, marking a decrease of 8.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.87. This value is within the healthy range. It has decreased from 47.93 (Mar 24) to 13.87, marking a decrease of 34.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.95. This value is within the healthy range. It has decreased from 35.74 (Mar 24) to 9.95, marking a decrease of 25.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 796.39. It has increased from 541.28 (Mar 24) to 796.39, marking an increase of 255.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 14.06. This value exceeds the healthy maximum of 3. It has increased from 5.33 (Mar 24) to 14.06, marking an increase of 8.73.
- For EV / EBITDA (X), as of Mar 25, the value is 13.66. This value is within the healthy range. It has increased from 6.88 (Mar 24) to 13.66, marking an increase of 6.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.40. This value exceeds the healthy maximum of 3. It has increased from 5.05 (Mar 24) to 13.40, marking an increase of 8.35.
- For Retention Ratios (%), as of Mar 25, the value is 80.90. This value exceeds the healthy maximum of 70. It has decreased from 90.43 (Mar 24) to 80.90, marking a decrease of 9.53.
- For Price / BV (X), as of Mar 25, the value is 1.39. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 1.39, marking an increase of 0.43.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.40. This value exceeds the healthy maximum of 3. It has increased from 5.05 (Mar 24) to 13.40, marking an increase of 8.35.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.05, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CP Capital Limited:
- Net Profit Margin: 66.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.99% (Industry Average ROCE: 12.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.98% (Industry Average ROE: 24.78%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.97 (Industry average Stock P/E: 119.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 66.4%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Village Tangori, Mohali Punjab 140601 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pramod Maheshwari | Chairman & M.D & CEO |
| Mr. Om Prakash Maheshwari | Executive Director & CFO |
| Mr. Nawal Kishore Maheshwari | Executive Director |
| Mrs. Neelima Maheshwari | Non Exe.Non Ind.Director |
| Mr. Neha Garg | Ind. Non-Executive Director |
| Mr. Nikhar Jain | Ind. Non-Executive Director |
| Mr. Jagdish Prasad Sarda | Ind. Non-Executive Director |
| Mrs. Divya Sodani | Ind. Non-Executive Director |
| Mr. Sanjay Khandelwal | Ind. Non-Executive Director |
| Mr. Akshaya Gupta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CP Capital Limited?
CP Capital Limited's intrinsic value (as of 07 March 2026) is ₹82.06 which is 10.80% lower the current market price of ₹92.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹167 Cr. market cap, FY2025-2026 high/low of ₹272/85.3, reserves of ₹533 Cr, and liabilities of ₹647 Cr.
What is the Market Cap of CP Capital Limited?
The Market Cap of CP Capital Limited is 167 Cr..
What is the current Stock Price of CP Capital Limited as on 07 March 2026?
The current stock price of CP Capital Limited as on 07 March 2026 is ₹92.0.
What is the High / Low of CP Capital Limited stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CP Capital Limited stocks is ₹272/85.3.
What is the Stock P/E of CP Capital Limited?
The Stock P/E of CP Capital Limited is 3.97.
What is the Book Value of CP Capital Limited?
The Book Value of CP Capital Limited is 303.
What is the Dividend Yield of CP Capital Limited?
The Dividend Yield of CP Capital Limited is 3.26 %.
What is the ROCE of CP Capital Limited?
The ROCE of CP Capital Limited is 9.83 %.
What is the ROE of CP Capital Limited?
The ROE of CP Capital Limited is 7.30 %.
What is the Face Value of CP Capital Limited?
The Face Value of CP Capital Limited is 10.0.
